In silico Exploration of Phytochemical based Thiazolidinone- Caffeic Acid- Indole New Chemical Entities for Simultaneous Management of Diabetes and Hypertension- A Fascinating Study.

Q2 Medicine
Kalyani Asgaonkar, Shital Patil, Yash Daga, Manjish Gupta, Ashwini Sagar, Krishna Shevate, Indrani Mahadik, Vrushali Randive
{"title":"<i>In silico</i> Exploration of Phytochemical based Thiazolidinone- Caffeic Acid- Indole New Chemical Entities for Simultaneous Management of Diabetes and Hypertension- A Fascinating Study.","authors":"Kalyani Asgaonkar,&nbsp;Shital Patil,&nbsp;Yash Daga,&nbsp;Manjish Gupta,&nbsp;Ashwini Sagar,&nbsp;Krishna Shevate,&nbsp;Indrani Mahadik,&nbsp;Vrushali Randive","doi":"10.2174/1871529X23666230414084918","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Past few decades have witnessed the co-existence of diabetes and hypertension leading to other health disorders. Hence, it is imperative to look into new therapies for the treatment of both hypertension and diabetes simultaneously in order to gradually reduce the pill burden and subsequent side effects.</p><p><strong>Objective: </strong>The goal of the current work was to use several in silico methods to develop new entities that have both anti-diabetic and anti-hypertensive activity.</p><p><strong>Methods: </strong>Structure activity relationship was drawn from the literature considering Thiazolidinones (Anti diabetes), Indole (Antihypertensive) and naturally occurring polyphenols (Dual activity) for simultaneous management of hypertension and diabetes. Fifty-six new chemical entities were designed and subjected to ADME and docking studies. Based on the Lipinski filter, bioavailability and lead likeness nineteen molecules were further docked into three PDB's (5Y2T, 4BVN, 1O8A).</p><p><strong>Results: </strong>The majority of the NCE's have shown higher binding affinities than the standard drugs, with Compound 42 having the best results. Among nineteen NCE's, 50% of the compounds have shown the involvement of Thiazolidinone, Indole and Catechol pharmacophores with prominent hydrogen bonds, hydrophobic, electrostatic and pi-pi stacking interactions with all three PDB's signifying their potential dual activity. Most favourable interactions were shown by compound 42.</p><p><strong>Conclusion: </strong>The results obtained are encouraging for further exploration of the hit molecules for simultaneous treatment of the two diseases.</p>","PeriodicalId":9543,"journal":{"name":"Cardiovascular and Hematological Disorders - Drug Targets","volume":" ","pages":"21-30"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular and Hematological Disorders - Drug Targets","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1871529X23666230414084918","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Past few decades have witnessed the co-existence of diabetes and hypertension leading to other health disorders. Hence, it is imperative to look into new therapies for the treatment of both hypertension and diabetes simultaneously in order to gradually reduce the pill burden and subsequent side effects.

Objective: The goal of the current work was to use several in silico methods to develop new entities that have both anti-diabetic and anti-hypertensive activity.

Methods: Structure activity relationship was drawn from the literature considering Thiazolidinones (Anti diabetes), Indole (Antihypertensive) and naturally occurring polyphenols (Dual activity) for simultaneous management of hypertension and diabetes. Fifty-six new chemical entities were designed and subjected to ADME and docking studies. Based on the Lipinski filter, bioavailability and lead likeness nineteen molecules were further docked into three PDB's (5Y2T, 4BVN, 1O8A).

Results: The majority of the NCE's have shown higher binding affinities than the standard drugs, with Compound 42 having the best results. Among nineteen NCE's, 50% of the compounds have shown the involvement of Thiazolidinone, Indole and Catechol pharmacophores with prominent hydrogen bonds, hydrophobic, electrostatic and pi-pi stacking interactions with all three PDB's signifying their potential dual activity. Most favourable interactions were shown by compound 42.

Conclusion: The results obtained are encouraging for further exploration of the hit molecules for simultaneous treatment of the two diseases.

基于植物化学的噻唑烷酮-咖啡酸-吲哚新化学物质同时治疗糖尿病和高血压的计算机探索——一项引人入胜的研究。
背景:在过去的几十年里,糖尿病和高血压共存,导致其他健康障碍。因此,迫切需要研究同时治疗高血压和糖尿病的新疗法,以逐步减少药物负担和随后的副作用。目的:当前工作的目标是使用几种计算机方法来开发具有抗糖尿病和抗高血压活性的新实体。方法:从文献中提取结构-活性关系,考虑噻唑烷酮(抗糖尿病)、吲哚(抗高血压)和天然多酚(双重活性)同时治疗高血压和糖尿病。设计了56个新的化学实体,并进行了ADME和对接研究。基于Lipinski过滤器,将19个分子的生物利用度和铅相似性进一步对接到三个PDB(5Y2T、4BVN、1O8A)中。结果:大多数NCE显示出比标准药物更高的结合亲和力,其中化合物42的结果最好。在19个NCE中,50%的化合物显示出噻唑烷酮、吲哚和儿茶酚药效团的参与,它们具有显著的氢键、疏水性、静电和π-π堆积相互作用,所有三个PDB都表明它们具有潜在的双重活性。化合物42显示出最有利的相互作用。结论:所获得的结果有助于进一步探索同时治疗这两种疾病的hit分子。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cardiovascular and Hematological Disorders - Drug Targets
Cardiovascular and Hematological Disorders - Drug Targets Medicine-Cardiology and Cardiovascular Medicine
CiteScore
1.90
自引率
0.00%
发文量
36
期刊介绍: Cardiovascular & Hematological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders. As the discovery, identification, characterization and validation of novel human drug targets for cardiovascular and hematological drug discovery continues to grow.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信